Home > Financial Ratios > PAR DRUGS AND CHEMICALS

PAR DRUGS AND CHEMICALS
Core EBITDA Growth

    Back to All Ratios
PAR DRUGS AND CHEMICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for PAR DRUGS AND CHEMICALS
Please provide your vote to see the results

PAR DRUGS AND CHEMICALS Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2023Mar2022Mar2021Mar2020Mar2019
   Core EBITDA Growth(%) 12.211.4669.7015.142.80

What is the latest Core EBITDA Growth ratio of PAR DRUGS AND CHEMICALS ?

The latest Core EBITDA Growth ratio of PAR DRUGS AND CHEMICALS is 12.21 based on Mar2023 Standalone results.
Year Core EBITDA Growth
Mar202312.21
Mar20221.46
Mar202169.70
Mar202015.14
Mar20192.80

How is Core EBITDA Growth of PAR DRUGS AND CHEMICALS Trending?

Years Core EBITDA Growth % Change
Mar2023 12.21
736.30
Mar2022 1.46
-97.91
Mar2021 69.7
360.37
Mar2020 15.14
440.71
Mar2019 2.8 -

Other Financial Ratios of PAR DRUGS AND CHEMICALS


Compare Core EBITDA Growth ratio of peers of PAR DRUGS AND CHEMICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PAR DRUGS AND CHEMICALS ₹303.6 Cr -5.3% 2.9% 55.2% Stock Analytics
PIDILITE INDUSTRIES ₹150,625.0 Cr 0.4% -1.7% 18.2% Stock Analytics
SOLAR INDUSTRIES INDIA ₹78,513.2 Cr 0.2% -0.5% 134.6% Stock Analytics
SRF ₹66,046.4 Cr -7.7% -14.1% -12% Stock Analytics
GUJARAT FLUOROCHEMICALS ₹35,397.5 Cr -8% -0.9% -1.1% Stock Analytics
DEEPAK NITRITE ₹33,873.2 Cr -1.1% 13.3% 28% Stock Analytics


PAR DRUGS AND CHEMICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
PAR DRUGS AND CHEMICALS

-5.3%

2.9%

55.2%

SENSEX

-1.5%

-2.6%

17.8%


You may also like the below Video Courses